More Than 100 Pradaxa Lawsuits Filed as Judge Sets Hearing Date

Share Article

The Web’s largest source for information on Pradaxa legal news, research and side effects is available at the Pradaxa Resource Center. Visit http://www.Pradaxa-lawsuits.org

Pradaxa Diagram
Anyone affected by internal bleeding or the loss of a loved one from Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.

The Pradaxa Resource Center, a patient advocacy group, is alerting those prescribed the blood thinner Pradaxa that experts have linked the drug to severe internal bleeding. More than 100 people alleging injury have now filed lawsuits against the manufacturer and a federal judge recently scheduled a hearing to plan the litigation.

Anyone affected by internal bleeding or the loss of a loved one from Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in patients with atrial fibrillation. According to an August 27, 2012 report in the Berlin Ad Hoc News, manufacturer Boehringer Ingelheim claims Pradaxa has been prescribed for a combined total of one million patient-years and has been used in more than 70 countries.

On December 7, 2011, however, the FDA warned that it would launch an investigation into Pradaxa after receiving more injury or death reports than expected. According to a USA Today article on August 19, 2012, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users last year, leading all other medications in 2011.

Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. According to a report issued by the United States Judicial Panel on Multidistrict Litigation on September 5, 2012, more than 100 actions have now been filed regarding Pradaxa side effects.

On July 17, 2012, Judge David Herndon, who will oversee the litigation, issued Case Management Order Number 1 – Initial Conference Order and Procedural Matters, which set an initial hearing for October 3, 2012 at 1:30 p.m, and indicated trials should start in 18 to 24 months.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.

To speak with a lawyer, or for more information on the research, warnings, Pradaxa side effects and legal options relating to the drug Pradaxa, visit http://www.Pradaxa-lawsuits.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website